Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension. 1988

M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
Service de Nephrologie et Hypertension Arterielle, Hôpital Foch, Université Paris-Ouest, France.

Renal haemodynamics and natriuresis were studied before and 6 h after oral intake of perindopril (8 mg) in eight hypertensive patients without renal failure. The patients were then treated with perindopril (8 mg per day) and renal haemodynamics were measured on the fifth day, 6 h after the morning intake. Sodium intake was controlled during the study (100 mmol sodium per day). Renal blood flow and the glomerular filtration rate were measured by the clearance method using 131I-hippuran and 125I-iothalamate, respectively. Mean blood pressure decreased from 135 to 110 after 6 h, and was 118 mmHg on the fifth day (P less than 0.001, respectively). Renal vascular resistance decreased significantly after acute drug intake from 0.19 to 0.15 arbitrary units (P less than 0.001) and on the fifth day to 0.16 arbitrary units (P less than 0.001). Renal blood flow rose from 708 to 723 after 6 h, and to 750 ml/min per 1.73 m2 on the fifth day but the change was no significant. There was no alteration in the glomerular filtration rate so that the filtration fraction decreased from 0.27 to 0.26 (after 6 h), and to 0.25 on the fifth day (P less than 0.02). Natriuresis increased after the first intake between the first and tenth hours. On the fifth day, maximum natriuresis was observed between the fourth and sixth hours. Perindopril caused strong renal vasodilation after the first intake and during the following days, with no change in the glomerular filtration rate. There was a significant decrease in the filtration fraction, indicating efferent, as well as afferent, arteriolar vasodilation.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
January 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
September 1997, European journal of clinical investigation,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
January 1991, Drugs,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
October 1990, Journal of human hypertension,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
January 1991, European journal of clinical pharmacology,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
July 1962, The American journal of medicine,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
April 1992, The American journal of medicine,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
January 1990, Drugs,
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
May 1979, Clinical science (London, England : 1979),
M Chaignon, and Z Barrou, and M Ayad, and M Lucsko, and P Aubert, and L Perret, and J Guedon
March 1992, Journal of internal medicine,
Copied contents to your clipboard!